Science-Backed Skeletal Strengthening Technology Coming Soon to the Southeast
AVENTURA, Fla., March 28, 2025 /PRNewswire/ — OsteoStrong, a global leader in skeletal strength and wellness, is excited to announce a new franchise sale in Aventura, Fla. This marks another step forward in the brand’s rapid growth, bringing its science-backed, drug-free approach to musculoskeletal health to the Southeastern U.S.
“OsteoStrong isn’t just a business — it’s a mission,” said Kyle Zagrodzky, Founder and CEO. “We’re excited to bring our proven system to Aventura, helping people build strength and vitality in a supportive, accessible environment.”
OsteoStrong’s global expansion continues to gain momentum, with new locations opening across the U.S. and around the world. As the brand grows to over 200 open centers, its mission remains clear: to help people strengthen their bodies and improve their quality of life through cutting-edge, science-backed technology.
With low overhead, recurring revenue, and full support from an experienced team, OsteoStrong positions franchisees for long-term success and meaningful impact—while tapping into the rising demand for proactive, longevity-focused health solutions.
“This new location serves as a key example of our sustained market growth,” said Jimmy Youngblood, President of OsteoStrong. “We’re always looking for mission-driven partners who want to bring this powerful technology to their markets.”
To learn more about franchise opportunities with OsteoStrong, visit: https://www.osteostrong.me/company/franchise/
About OsteoStrong®
OsteoStrong® is a science-backed, technology-driven system designed to improve bone density, strength, and overall skeletal health. With locations worldwide, OsteoStrong® helps people of all ages build stronger bones in a safe, efficient, and drug-free manner.
For more information about OsteoStrong®, visit www.osteostrong.me.
Media Contact
Interdependence Public Relations
949-259-6377 x 225
392572@email4pr.com
SOURCE OsteoStrong
The New Year Introduces Continuum's Entry-Level Tier, Starting at $25,000 Per YearNEW YORK, Dec. 22,…
BOSTON, Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with…
CHICAGO, Dec. 22, 2025 /PRNewswire/ -- TrustCommerce®, a Sphere company and leading provider of end-to-end…
MIAMI, Dec. 22, 2025 /PRNewswire/ -- BioFlorida, Inc. ("BioFlorida"), Florida's preeminent life sciences association, is…
Andreessen Horowitz leads the funding round which will accelerate the company's leadingtelehealth marketplaceAUSTIN, Texas, Dec.…
MMJ's position is further fortified by its FDA Orphan Drug Designations for the treatment of…